Dacomitinib as first-line treatment in patients with clinically or molecularly selected advanced non-small-cell lung cancer: a multicentre, open-label, phase 2 trial
収録刊行物
-
- The Lancet Oncology
-
The Lancet Oncology 15 (13), 1433-1441, 2014-12
Elsevier BV